Connect with us

India

Vaccination landmark in Uttar Pradesh: 50% of eligible population get 1st dose of vaccine

Despite being the most populous state, Uttar Pradesh is racing past other Indian states in attempting to mitigate the anticipated third wave of Covid-19 infections through vaccination.

Published

on

In Open letter, 152 dignitaries defend Yogi govt; rebut allegations of ex-bureaucrats
Advertisement

New Delhi: UP’s Covid-19 vaccination drive is showing remarkable progress. In a significant achievement by the state, Uttar Pradesh on Thursday completed administering at least one dose of Covid-19 vaccine to half of its eligible adult population, as it crossed 9.05 crore cumulative vaccinations across the state.

As per official estimates based on census and electoral data, around 15 crore people in UP are to be vaccinated. Of these, 7.50 crore have received at least one dose which is about 50 percent against the target.

Half of state protected against the Covid-19 infection

While over 1.54 crore people are fully vaccinated in the State. Despite being the most populous state, Uttar Pradesh is racing past other Indian states in attempting to mitigate the anticipated third wave of Covid-19 infections through vaccination.

Yogi - vaccination

Highest in the country! UP administers over 9.05 crore Covid vaccine doses

Soaring high on vaccination, on Wednesday, the state has achieved the target of vaccinating 9 crore people since the launch of the nationwide vaccination drive in January, which is a record.

In line with the Chief Minister’s order, the health department is conducting vaccination at war footing. Time-to-time mega vaccination campaigns are being held in the state.

Yogi, hospital, Covid

Over 7.50 crore received at least one dose

50 per cent single dose coverage of the adult population has significant public health implications: it means a significant percentage of the population has a certain level of protection against the infection.

The government has asked the health department to focus on enhancing second dose coverage.

Advertisement